Studies on Macrobial Metabolites Effective to Eucaryotic Cells

对真核细胞有效的微生物代谢产物的研究

基本信息

  • 批准号:
    60303026
  • 负责人:
  • 金额:
    $ 4.1万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Co-operative Research (A)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1987
  • 项目状态:
    已结题

项目摘要

YAMAZAKI isolated monoamine oxidase oxidase inhibitors, EA-1, TA-1, TL-1 and norsolorinic acid, as the metaboltes Emericella navahoensis and Talaromyces lutens, and their specific sctivity was clarified. OMURA searched for pletelet aggregation inhibitors form the metaboltes of Actinomycetes, and found such activity in several quinone antibiotics such as medermycin and nanaomycin. A new isotetracenoid, OM-4842, was slso identified. SUZUKI determined the total structure of N-acetylsporaviridin and the partial atructure of aculeximycin. MIKAMI prepared a vriety of derivatives of saframycin, an antitumor antibiotic, and structure-activity relationship was studied. YAMAMOTO searched for anti-L5178Y cell compounds, and isolated monorden from Macrophoma castaneicola, tyrosol from Glomellera cingulate and norbotryal etc from Botrytis cinerea. NAKAMURA determined the structures of neo-enactins, antifungal antibiotics. Their activities were evaluated. YAMAGUCHI searched for antifungal antibiotics by a screening system using a wild type and a mutant strains of Candida albicans and isolated a compound. NATORI studied on the metabolites of Phomopsis sp., and isolated a varietyof cytochalasan compounds. SATO found that diethylstibestrol (DES) effects on myclotubule assembly. The action of DES and related compounds were studied. NOZOE studied on the metabolitesd of Basidiomycete, and isolated several antibiotics. FUJITA studied on the peptidic containing -amino-isobutylic acid as their components, and their structures were established. OKUDA and IWASAKI isolated several anti-mitotic compounds and their mode of action was studied. A screening system using Pyricularia oryzae was also deviced.
YAMAZAKI分离出单胺氧化酶氧化酶抑制剂EA-1、TA-1、TL-1和去盐酸,作为纳瓦霍青Emericella navahoensis和Talaromyces lutens的代谢物,并明确了它们的特异性活性。OMURA在放线菌代谢产物中寻找pletellet聚集抑制剂,并在几种醌类抗生素如甲德霉素和纳霉素中发现了这种活性。一个新的类异四烯化合物OM-4842也被鉴定出来。SUZUKI测定了n -乙酰sporaviridin的总结构和阿霉素的部分结构。MIKAMI制备了多种抗肿瘤抗生素saframycin衍生物,并对其构效关系进行了研究。YAMAMOTO寻找抗l5178y细胞化合物,从castaneicola巨噬细胞中分离到monorden,从Glomellera cingulate中分离到tyrosol,从Botrytis cinerea中分离到norbotryal等。NAKAMURA测定了抗真菌抗生素neo-enactins的结构。他们的活动被评估。YAMAGUCHI通过使用野生型和突变型白色念珠菌的筛选系统寻找抗真菌抗生素,并分离出一种化合物。NATORI对磷芥(Phomopsis sp.)的代谢产物进行了研究,分离出多种胞沙三酸化合物。佐藤发现二乙基雌酚(DES)对微管组装的影响。研究了DES及其相关化合物的作用。NOZOE对担子菌的代谢产物进行了研究,并分离出几种抗生素。FUJITA对含-氨基异丁酸的肽进行了研究,并确定了它们的结构。OKUDA和IWASAKI分离了几种抗有丝分裂化合物,并研究了它们的作用方式。并设计了利用稻瘟霉进行筛选的系统。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
矢沢勝清: J.Antibiotics. 39. 1639-1650 (1986)
Katsukiyo Yazawa:J.抗生素。39。1639-1650(1986)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大村 智: J.Antibiolics.39. 1180-1181 (1986)
Satoshi Omura:J.Antibiolics.39。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
佐藤良博: J.Biochem.101. 1247-1252 (1987)
佐藤义宏:J.Biochem.101。1247-1252(1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
岩崎成夫: Chem. Pharm. Bull.34. 1384-1390 (1986)
岩崎茂夫:化学公报 1384-1390 (1986)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
草野源次郎: Chem.Pgarm.Bull. 35. 3482-3486 (1487)
草野源次郎:Chem.Pgarm.Bull 35. 3482-3486 (1487)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IWASAKI Shigeo其他文献

IWASAKI Shigeo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IWASAKI Shigeo', 18)}}的其他基金

STUDIES ON THE ANTIMITOTIC AGENTS-TUBULIN INTERACTION AND DRUG DESIGN
抗有丝分裂剂-微管蛋白相互作用及药物设计的研究
  • 批准号:
    08407070
  • 财政年份:
    1996
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Regulators of Microtubule Assembly : Molecular Recognition Mechanism and Developement of New Regulators.
微管组装调节器:分子识别机制和新型调节器的开发。
  • 批准号:
    05453178
  • 财政年份:
    1993
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
STUDY ON THE MICROBIAL METABOLITRES AS THE MEDICINAL RESOURCES
微生物代谢产物作为药用资源的研究
  • 批准号:
    03303013
  • 财政年份:
    1991
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Co-operative Research (A)
Bio-organic Studies on Inhibition of Tubulin Assembly by Mitosis Inhibitors
有丝分裂抑制剂抑制微管蛋白组装的生物有机研究
  • 批准号:
    63470127
  • 财政年份:
    1988
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation
软骨微生物产品作为膝骨关节炎表观遗传失调的新驱动因素
  • 批准号:
    10588964
  • 财政年份:
    2022
  • 资助金额:
    $ 4.1万
  • 项目类别:
Drug discovery through identification of microbial products against SARS-CoV-2 proteases
通过鉴定抗 SARS-CoV-2 蛋白酶的微生物产物来发现药物
  • 批准号:
    22K06692
  • 财政年份:
    2022
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Measuring the immune and antimicrobial impact of gut microbial products
测量肠道微生物产品的免疫和抗菌影响
  • 批准号:
    552392-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 4.1万
  • 项目类别:
    University Undergraduate Student Research Awards
Evaluation of cell free microbial products in commercial greenhouses
商业温室中无细胞微生物产品的评估
  • 批准号:
    493072-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
Modification of the microbiome and utilisation of microbial products as novel treatments for COPD
微生物组的修饰和微生物产品的利用作为慢性阻塞性肺病的新疗法
  • 批准号:
    nhmrc : 1059239
  • 财政年份:
    2014
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Project Grants
Construction of the database of microbial products and its application study
微生物产品数据库的构建及其应用研究
  • 批准号:
    24248022
  • 财政年份:
    2012
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Marine Microbial Products as Novel Agents Against Neurotropic Arboviruses
海洋微生物产品作为对抗嗜神经虫媒病毒的新药物
  • 批准号:
    8339439
  • 财政年份:
    2011
  • 资助金额:
    $ 4.1万
  • 项目类别:
Marine Microbial Products as Novel Agents Against Neurotropic Arboviruses
海洋微生物产品作为对抗嗜神经虫媒病毒的新药物
  • 批准号:
    8082413
  • 财政年份:
    2011
  • 资助金额:
    $ 4.1万
  • 项目类别:
Counterregulation of adaptive immune responses by systemic microbial products via indoleamine 2,3-dioxigenase (IDO) in the spleen (A14+)
全身微生物产物通过脾脏中吲哚胺 2,3-双加氧酶 (IDO) 反调节适应性免疫反应 (A14)
  • 批准号:
    17321108
  • 财政年份:
    2006
  • 资助金额:
    $ 4.1万
  • 项目类别:
    Collaborative Research Centres
Early Life Exposure to Microbial Products and Asthma
生命早期接触微生物产品与哮喘
  • 批准号:
    6928582
  • 财政年份:
    2004
  • 资助金额:
    $ 4.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了